<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>同写意 | wechat-feeds</title><link>http://MzA4MzgzMDM5Mg.favicon.privacyhide.com/favicon.ico</link><description>一个以新药创制为核心，汇集国内一流研发精英的大型交流与价值分享平台。“同筑技术人生路，写意中国新药魂”是同写意的初衷与愿景。秉承汇集“一线、一流”，讲求“实用、实在、时效”的原则。</description><managingEditor> (hellodword)</managingEditor><pubDate>Sun, 07 Mar 2021 20:16:49 +0800</pubDate><image><url>http://MzA4MzgzMDM5Mg.favicon.privacyhide.com/favicon.ico</url><title>同写意 | wechat-feeds</title><link>http://MzA4MzgzMDM5Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>写意报告丨mRNA核酸抗体扬帆起航</title><link>https://mp.weixin.qq.com/s/ZiycLnoz3JT1MalWwZ_LRg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2Ca2CTt3GPresnvY14ib8g13VJrH6Khz5tQRIibPnsCrOUyMP3sCYVMXjL9wpCQy8nAAww3UOvzZp1g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>mRNA疗法很可能在未来几年进一步发展和改善。]]></content:encoded><pubDate>Sun, 07 Mar 2021 19:09:38 +0800</pubDate></item><item><title>欧洲药品管理局EMA发布关于etesevimab和bamlanivimab双抗体疗法在欧盟治疗COVID-19确诊患者的建议</title><link>https://mp.weixin.qq.com/s/FGtqgOr1AbUwwyGffbyE7Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2AXqBSY2OJiaHw1mL77o3icuCAwyMicueyH6frqyNKXLSMEdw7YdgfADpIU8gERGAdILToRYHdYQcDwQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>此双抗体疗法已在美国和意大利获得紧急使用授权。]]></content:encoded><pubDate>Sun, 07 Mar 2021 19:09:38 +0800</pubDate></item><item><title>9周年，“久久”如一</title><link>https://mp.weixin.qq.com/s/kxTZcIJhTLaR0hyQ6n9xKg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2AXqBSY2OJiaHw1mL77o3icuCn84g4Eibec5Gws5Egl1Zicr7hdv3LRmnhpKV1WoNyZTMic6AvuNzBiaOgA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>我们一直在路上。]]></content:encoded><pubDate>Sun, 07 Mar 2021 19:09:38 +0800</pubDate></item><item><title>2021年以来，高瓴创投已投资的12家中国生物医药公司，它们有何亮点？</title><link>https://mp.weixin.qq.com/s/uYZQq__hyNI3OxL82NJx4g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2AXqBSY2OJiaHw1mL77o3icuCEfcf0qSicicamVCoGgY61BZyrrhTnWVS9wU1zQ7MuaYLon4FnsUetpFw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>这12家生物医药公司都有哪些？]]></content:encoded><pubDate>Sun, 07 Mar 2021 19:09:38 +0800</pubDate></item><item><title>《柳叶刀-肿瘤学》：KRAS靶向抗癌药迎来首个NDA，有望撕下“不可成药”标签</title><link>https://mp.weixin.qq.com/s/k45uGyMSuWus79LnEIil-w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2AXqBSY2OJiaHw1mL77o3icuCUBMQsjKkicAjkgSqyM4a8UCzmYP9ialBkyZnKiagm9S2gIrtw5VTGYQZQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>百济神州、加科思药业等多家中国公司均涉足。]]></content:encoded><pubDate>Sun, 07 Mar 2021 19:09:38 +0800</pubDate></item><item><title>中药新药注册法规变迁、申报审批及未来开发策略</title><link>https://mp.weixin.qq.com/s/8KvzgcfVBm-FKFaWXVP7IA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2CHJDmBe0B8ua9Q6HOSa0S1AjMBrFmqSsZHqQtIrTLo9opmjQUYGuspHMkUjW50syEHFv4ibnkrLBw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>如题。]]></content:encoded><pubDate>Sat, 06 Mar 2021 17:38:41 +0800</pubDate></item><item><title>写意发布丨鸿运华宁生物医药与招商局集团健康板块战略合作暨C轮融资签约</title><link>https://mp.weixin.qq.com/s/h5zFZXAsdG2dmMIaEg_c-w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2DOY9J6MV6u1nU3zWmN5xc7R6ibJy8NlIvIM0seccrnHIJ3EviblpU3MsKK0IGdDYic3ibAMJbteddbLw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>鸿运华宁生物医药C轮融资逾7800万美元。]]></content:encoded><pubDate>Sat, 06 Mar 2021 17:38:41 +0800</pubDate></item><item><title>水凝胶：mRNA疫苗递送新方案，活性至少30天可持久预防癌症</title><link>https://mp.weixin.qq.com/s/cQmDV7Vh6kp4Kf_Somf_5w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2DOY9J6MV6u1nU3zWmN5xc7FtfIhJsDAh73dvicGiazwuiccMDichAibawPOC5b25kbcCz4zHMiamyy27fg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>近日，国家纳米科学中心开发了一种由纳米材料制成的水凝胶。]]></content:encoded><pubDate>Sat, 06 Mar 2021 17:38:41 +0800</pubDate></item><item><title>百奥泰终止两ADC项目，如何理性对待创新药的开发风险？</title><link>https://mp.weixin.qq.com/s/yU2-saAOa2NdP9w87YN61Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2C0FRFUOfD5j2icG80BhEWy3T6D7vMGJUibl3Burjnib3NNjpQX2VEcqGrC7tiaBQScvySTHPFSfXZI2A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>创新药还是只能百花齐放。]]></content:encoded><pubDate>Fri, 05 Mar 2021 19:22:14 +0800</pubDate></item><item><title>关注杜丨儿童多动症患者的福音，一款新药获FDA批准</title><link>https://mp.weixin.qq.com/s/f_XjEX_ejT260-Z-vwFDiQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2C0FRFUOfD5j2icG80BhEWy3LAJXbvvibeoey6af82Kuls33Al6Vciby6E2eic0PTcZuvm14wxIgsB1MQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>美国FDA宣布批准KemPharm公司的AZSTARYS™上市。]]></content:encoded><pubDate>Fri, 05 Mar 2021 19:22:14 +0800</pubDate></item><item><title>2021“创新力·中国行” ——吹响医药创新集结号，奏响生命科学的中国乐章！</title><link>https://mp.weixin.qq.com/s/E9NRRevvS1VeYw8vpkMkRw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2C0FRFUOfD5j2icG80BhEWy3IHg62d9Sw4otehXIkgWM8pf7EkGnA8fmd1IuWWeOrvNibOCQCq2b3JA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>惟创新者行稳致远。]]></content:encoded><pubDate>Fri, 05 Mar 2021 19:22:14 +0800</pubDate></item><item><title>写意人物丨田文志：创新药的分化时刻，那些需要三思的危与机</title><link>https://mp.weixin.qq.com/s/bjYtgRMd4CjjjyUeaYe36w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2CHJDmBe0B8ua9Q6HOSa0S10KXGj6XP95Jd01G6zt2TpQPuCfadx6CAicLGNrS50dlZ6GyQJSBNTlQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>开发ADC还是双抗？这是个问题。]]></content:encoded><pubDate>Wed, 03 Mar 2021 23:47:20 +0800</pubDate></item><item><title>同写意论坛第113期丨医药项目合作与投资并购专家之路（NEW）</title><link>https://mp.weixin.qq.com/s/B7aORw2HduFBoi_3FtmEHg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2CHJDmBe0B8ua9Q6HOSa0S1LpLQY9OuE7NK0OU6tuPJzIiaEazAtXA4b9F01NFfpehAystwfQWU9Cw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>同写意“医药项目合作与投资并购专家之路”论坛，3月27日-28日，苏州见！]]></content:encoded><pubDate>Wed, 03 Mar 2021 23:47:20 +0800</pubDate></item><item><title>刘国恩谈创新药的药物经济学测算是怎么做的</title><link>https://mp.weixin.qq.com/s/AHFQQdggAIEzfYJU-P4Jaw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2CHJDmBe0B8ua9Q6HOSa0S1ukyMyGQCm3Ho6lMzT6dciaTqB3hosMwdLpFE9RNJaFQsl3ZFMLZamrg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>如题。]]></content:encoded><pubDate>Wed, 03 Mar 2021 23:47:20 +0800</pubDate></item><item><title>植德写意丨药品专利链接，来了！——《专利法修正案（草案二次审议稿）》关于药品专利链接有关条文的修改解读</title><link>https://mp.weixin.qq.com/s/uQ3_FIUG2wOUmWPP1GxnYw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2CHJDmBe0B8ua9Q6HOSa0S1riafA1KP1rxNBmNtKDbvmd9KnYiaMAYoCicSjUuDVuGE8DNUMg48ARrUQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>药品专利链接制度在我国将如何落地终于初现端倪。]]></content:encoded><pubDate>Wed, 03 Mar 2021 18:01:40 +0800</pubDate></item><item><title>治疗型肿瘤mRNA疫苗初显临床疗效</title><link>https://mp.weixin.qq.com/s/qGbnxJiAq7H05WAGKHxGrQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2CHJDmBe0B8ua9Q6HOSa0S1NseuHyb2FTqbUB5y4kmI4W5bGbFl1iagsDIR7zqjEAoejv12aDZBlRg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>Moderna公布了mRNA肿瘤疫苗的Ⅰ期临床结果。]]></content:encoded><pubDate>Wed, 03 Mar 2021 18:01:40 +0800</pubDate></item><item><title>写意云课丨第66期：免疫原性风险评估——如何通过In-Silico和In-Vitro工具来筛选和优化先导候选药物？</title><link>https://mp.weixin.qq.com/s/e8QlSz744VR5efohSCPQtg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2CHJDmBe0B8ua9Q6HOSa0S1MaVVichx4h6jGIpjI0DQicP60N7DY4ZwBLZC7x17icTNO2bvH1U3RB10Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>2021/3/4（周四），
15:00-16:00。]]></content:encoded><pubDate>Wed, 03 Mar 2021 18:01:40 +0800</pubDate></item><item><title>同写意丨药明直播间：CMC系列(十一)——临床前新药CMC的关键风险分析与应对</title><link>https://mp.weixin.qq.com/s/F6tWk8G6iCmrVdIgaY1F2A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2CHJDmBe0B8ua9Q6HOSa0S1CxrIm0CupcL3sjDuZyKtqCpialOhU379fZHEiaib1vLP2OwmqKFn3WW4A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>3月4日，15:00-16:30。]]></content:encoded><pubDate>Wed, 03 Mar 2021 18:01:40 +0800</pubDate></item><item><title>同写意第114期丨抗体药先进工艺与产业化发展峰会</title><link>https://mp.weixin.qq.com/s/S5x41NEhNnH8u07cZZnJpw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2Ca2CTt3GPresnvY14ib8g13oVmldwcnmhQ0ic3jeI48oVNdM9prTDmfUxjsmPgcq6Hz0zbI2j7gIicg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>同写意联合中国医药设备工程协会举办抗体药产业化大会。]]></content:encoded><pubDate>Tue, 02 Mar 2021 19:57:37 +0800</pubDate></item><item><title>和传统的昨天告别</title><link>https://mp.weixin.qq.com/s/LXlFlv-6UPSKQgIwcDYEGA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/sz_mmbiz_jpg/CeH9Phpxe2Ca2CTt3GPresnvY14ib8g13ibHxUnxBHnDnOWFFeibvbhGL70vGYhrdEX1go43ua4TkqhhyXc9O40pg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>智能预警赢先机。]]></content:encoded><pubDate>Tue, 02 Mar 2021 19:57:37 +0800</pubDate></item></channel></rss>